<?xml version="1.0" encoding="UTF-8"?>
<ref id="B130-pharmaceutics-12-00171">
 <label>130.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pollock</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Dwek</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Burton</surname>
    <given-names>D.R.</given-names>
   </name>
   <name>
    <surname>Zitzmann</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery</article-title>
  <source>AIDS</source>
  <year>2008</year>
  <volume>22</volume>
  <fpage>1961</fpage>
  <lpage>1969</lpage>
  <pub-id pub-id-type="doi">10.1097/QAD.0b013e32830efd96</pub-id>
  <?supplied-pmid 18753929?>
  <pub-id pub-id-type="pmid">18753929</pub-id>
 </element-citation>
</ref>
